Published in Hepatology on October 01, 2005
Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model. World J Gastroenterol (2012) 0.83
Late onset fulminant Wilson's disease: a case report and review of the literature. World J Gastroenterol (2014) 0.75
The genetics of Wilson disease. Handb Clin Neurol (2017) 0.75
Wilson disease in septuagenarian siblings: Raising the bar for diagnosis. Hepatology (2005) 1.99
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
The Budd-Chiari syndrome. N Engl J Med (2004) 3.95
Acute-on chronic liver failure. J Hepatol (2012) 3.74
Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Splanchnic artery aneurysms. Mayo Clin Proc (2007) 2.55
Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology (2007) 2.36
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34
Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology (2014) 2.27
Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology (2008) 2.26
Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology (2006) 2.25
Mesenteric venous thrombosis. Mayo Clin Proc (2013) 2.09
A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology (2008) 2.02
Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet (2004) 1.96
Performance standards for therapeutic abdominal paracentesis. Hepatology (2004) 1.93
Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem (2003) 1.92
Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab (2004) 1.91
Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant (2004) 1.87
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl (2007) 1.86
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl (2003) 1.83
Hepatocellular carcinoma after the Fontan procedure. N Engl J Med (2013) 1.81
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology (2012) 1.74
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet (2004) 1.66
Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology (2005) 1.65
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65
Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology (2003) 1.65
Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening. Clin Chem (2008) 1.55
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet (2003) 1.47
Next generation sequence analysis for mitochondrial disorders. Genome Med (2009) 1.42
Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl (2007) 1.39
Medical and surgical treatment options for polycystic liver disease. Hepatology (2010) 1.39
Clinical profile of autosomal dominant polycystic liver disease. Hepatology (2003) 1.37
Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol (2009) 1.37
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2008) 1.35
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.33
Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care (2011) 1.33
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc (2003) 1.30
Preserving personal autonomy in a genomic testing era. Genet Med (2013) 1.25
Acute superior mesenteric venous thrombosis: one disease or two? Am J Gastroenterol (2003) 1.24
Implementing individualized medicine into the medical practice. Am J Med Genet C Semin Med Genet (2014) 1.21
Evaluation of oligonucleotide sequence capture arrays and comparison of next-generation sequencing platforms for use in molecular diagnostics. Clin Chem (2010) 1.18
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
Congenital heart disease and the liver. Hepatology (2012) 1.12
Ectopic varices in the gastrointestinal tract: short- and long-term outcomes of percutaneous therapy. Cardiovasc Intervent Radiol (2005) 1.09
Embolization of spontaneous portosystemic shunts for management of severe persistent hepatic encephalopathy. Hepatology (2013) 1.09
Medical and ethical aspects of long-term enteral tube feeding. Mayo Clin Proc (2005) 1.05
Clinical molecular diagnosis of Wilson disease. Semin Liver Dis (2011) 1.05
Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl (2005) 1.02
Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc (2006) 1.02
Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin Proc (2005) 1.02
Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl (2003) 1.01
Bacterial infections in end-stage liver disease: current challenges and future directions. Gut (2012) 1.00
Expanding DNA diagnostic panel testing: is more better? Expert Rev Mol Diagn (2011) 1.00
Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc (2011) 0.98
The role of viral integration in the development of cervical cancer. Cancer Genet Cytogenet (2005) 0.96
Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum. Pediatr Int (2012) 0.96
Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures. J Neurosci Methods (2009) 0.96
Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology (2015) 0.94
Natural history of cirrhosis. Curr Gastroenterol Rep (2013) 0.94
APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests. J Mol Diagn (2012) 0.93
Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. Mol Genet Metab (2006) 0.92
Cancer antigen 125 in patients with chronic liver disease. Mayo Clin Proc (2002) 0.91
Duodenal diverticulosis in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2006) 0.91
Impact factor: misused and overhyped? Hepatology (2009) 0.90
Automated spectrophotometric analysis of mitochondrial respiratory chain complex enzyme activities in cultured skin fibroblasts. Clin Chem (2005) 0.89
Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment? Arch Pathol Lab Med (2004) 0.89
Quality improvement of mitochondrial respiratory chain complex enzyme assays using Caenorhabditis elegans. Genet Med (2011) 0.88
Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta (2005) 0.88
Race and receipt of liver transplantation: location matters. Liver Transpl (2010) 0.88
Is the change in MELD score a better indicator of mortality than baseline MELD score? Liver Transpl (2003) 0.88
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am J Surg Pathol (2006) 0.88
Heart and liver disease in 32 patients undergoing biopsy of both organs, with implications for heart or liver transplantation. Mayo Clin Proc (2004) 0.87
Development of a newborn screening follow-up algorithm for the diagnosis of isobutyryl-CoA dehydrogenase deficiency. Genet Med (2007) 0.87
Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonadal mosaicism. Am J Med Genet A (2014) 0.86
Hematological malignancy manifesting as ascites. Nat Clin Pract Gastroenterol Hepatol (2005) 0.86
A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma. Ophthalmic Genet (2006) 0.85
Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl (2003) 0.84
Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes. Childs Nerv Syst (2007) 0.84
Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort. BMJ Open (2013) 0.83
Dysphagia lusoria. Mayo Clin Proc (2012) 0.83
Cardiac surgery in kidney and liver transplant recipients. Mayo Clin Proc (2006) 0.82
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int (2013) 0.82
Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome. Liver Transpl (2006) 0.82
Cardiomyopathy associated with celiac disease. Mayo Clin Proc (2005) 0.82
Acute-on-chronic liver failure: what are the implications? Curr Gastroenterol Rep (2012) 0.81
Genotype-phenotype correlation in Wilson disease. J Clin Gastroenterol (2010) 0.81
Perioperative risk assessment for patients with cirrhosis and liver disease. Expert Rev Gastroenterol Hepatol (2009) 0.81
Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Mol Genet Metab (2006) 0.81
Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS/MS. Mol Genet Metab (2013) 0.80
Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology (2011) 0.80
Normal muscle respiratory chain enzymes can complicate mitochondrial disease diagnosis. Pediatr Neurol (2006) 0.80
Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl (2007) 0.79